Agreement Signed For a Total of 15 Clinical Trial Studies
July, 2026
We specialise in developing, licensing, and distributing complex pharmaceutical formulations.
Focusing on niche and value-added pharmaceuticals products across multiple dosage forms, expanding patient access to treatments and support.
For more than 25 years, our team at SIINOVIA has successfully developed and launched over 200 generic products, many of which were first-to-market complex generics with no competition for decades.
Consistent ability to develop and bring to market complex, niche generics.
With a strong focus on innovation, the company is committed to developing value-added medicines that address unmet medical needs.
Our research and development has a global impact, making a difference to the lives of humans, animals, and our society as a whole.
July, 2026
July, 2026
July, 2026
July, 2026
Have a licensing proposal, product inquiry, or partnership opportunity? We are dedicated to providing clear, responsive, and expert communication.